Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Alessia Dalla Pria, Katy Hayward & Mark Bower. (2013) Do we still need chemotherapy for AIDS-associated Kaposi’s sarcoma?. Expert Review of Anticancer Therapy 13:2, pages 203-209.
Read now
Read now
Francesca Cainelli & Alfredo Vallone. (2009) Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi’s sarcoma. Biologics: Targets and Therapy 3, pages 385-390.
Read now
Read now
Ashish Udhrain, Keith M Skubitz & Donald W Northfelt. (2007) Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi’s sarcoma. International Journal of Nanomedicine 2:3, pages 345-352.
Read now
Read now
Alexander Kreuter, Heinrich Rasokat, Mariam Klouche, Stefan Esser, Armin Bader, Thilo Gambichler, Peter Altmeyer & Norbert H. Brockmeyer. (2005) Liposomal Pegylated Doxorubicin versus Low-Dose Recombinant Interferon Alfa-2a in the Treatment of Advanced Classic Kaposi's Sarcoma; Retrospective Analysis of Three German Centers. Cancer Investigation 23:8, pages 653-659.
Read now
Read now
Articles from other publishers (26)
Ramya Ramaswami, Thomas S. Uldrick, Mark N. Polizzotto, Kathleen M. Wyvill, Priscila Goncalves, Anaida Widell, Kathryn Lurain, Seth M. Steinberg, William Douglas Figg, Giovanna Tosato, Denise Whitby & Robert Yarchoan. (2019) A Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab followed by Bevacizumab Monotherapy in Patients with Advanced Kaposi Sarcoma. Clinical Cancer Research 25:14, pages 4238-4247.
Crossref
Crossref
C. Requena, M. Alsina, D. Morgado-Carrasco, J. Cruz, O. Sanmartín, C. Serra-Guillén & B. Llombart. (2018) Kaposi Sarcoma and Cutaneous Angiosarcoma: Guidelines for Diagnosis and Treatment. Actas Dermo-Sifiliográficas (English Edition) 109:10, pages 878-887.
Crossref
Crossref
C. Requena, M. Alsina, D. Morgado-Carrasco, J. Cruz, O. Sanmartín, C. Serra-Guillén & B. Llombart. (2018) Sarcoma de Kaposi y angiosarcoma cutáneo: directrices para el diagnóstico y tratamiento. Actas Dermo-Sifiliográficas 109:10, pages 878-887.
Crossref
Crossref
Watson Mtonga, Aaron Mujajati, Derick Munkombwe, Aubrey Kalungia, Lungwani Tyson Muungo, John West, Charles Wood & Owen Ngalamika. (2018) Therapeutic Outcomes in AIDS-Associated Kaposi's Sarcoma Patients on Antiretroviral Therapy Treated with Chemotherapy at Two Tertiary Hospitals in Lusaka, Zambia. Current HIV Research 16:3, pages 231-236.
Crossref
Crossref
Canrong Zhong, Mengyang Xu, Yan Wang, Jun Xu & Yan Yuan. (2017) An APE1 inhibitor reveals critical roles of the redox function of APE1 in KSHV replication and pathogenic phenotypes. PLOS Pathogens 13:4, pages e1006289.
Crossref
Crossref
Jie Qin & Chun Lu. 2017. Infectious Agents Associated Cancers: Epidemiology and Molecular Biology. Infectious Agents Associated Cancers: Epidemiology and Molecular Biology
237
251
.
Oluwatoyin F Gbabe, Charles I Okwundu, Martin Dedicoat & Esther E Freeman. (2014) Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Brian Thabile Flepisi, Patrick Bouic, Gerhard Sissolak & Bernd Rosenkranz. (2014) Drug–drug interactions in HIV positive cancer patients. Biomedicine & Pharmacotherapy 68:5, pages 665-677.
Crossref
Crossref
Ryoji Yoshida, Hideki Nakayama, Nozomu Takahashi, Masashi Nagata, Takuya Tanaka, Masafumi Nakamoto, Hideto Sato, Toshikazu Miyakawa, Hiroaki Mitsuya & Masanori Shinohara. (2014) A case of AIDS-associated oral Kaposi's sarcoma of the tongue. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 26:2, pages 170-174.
Crossref
Crossref
Alessandra Latini, Carlo Cota, Virginia Ferraresi, Paola Cordiali-Fei, Massimo Giuliani, Elisabetta Trento, Mauro Zaccarelli, Antonio Bonadies, Aldo Di Carlo & Guido Palamara. (2013) Radiation recall dermatitis in course of epidemic Kaposi's sarcoma. Dermatologic Therapy, pages n/a-n/a.
Crossref
Crossref
Mark Bower, Justin Weir, Nicholas Francis, Tom Newsom-Davis, Sam Powles, Tim Crook, Marta Boffito, Brian Gazzard & Mark Nelson. (2009) The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma. AIDS 23:13, pages 1701-1706.
Crossref
Crossref
Shima Uneda, Shogo Murata, Takashi Sonoki, Hiroshi Matsuoka & Hideki Nakakuma. (2009) Successful treatment with liposomal doxorubicin for widespread Kaposi’s sarcoma and human herpesvirus-8 related severe hemophagocytic syndrome in a patient with acquired immunodeficiency syndrome. International Journal of Hematology 89:2, pages 195-200.
Crossref
Crossref
L. Martín‐Carbonero, R. Palacios, E. Valencia, P. Saballs, G. Sirera, I. Santos, F. Baldobí, M. Alegre, A. Goyenechea, J. Pedreira, J. González del Castillo, J. Martínez‐Lacasa, A. Ocampo, M. Alsina, J. Santos, D. Podzamczer & J. González‐Lahoz. (2008) Long‐Term Prognosis of HIV‐Infected Patients with Kaposi Sarcoma Treated with Pegylated Liposomal Doxorubicin. Clinical Infectious Diseases 47:3, pages 410-417.
Crossref
Crossref
Huong Q Nguyen, Amalia S Magaret, Mari M Kitahata, Stephen E Van Rompaey, Anna Wald & Corey Casper. (2008) Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response. AIDS 22:8, pages 937-945.
Crossref
Crossref
Richard F. Ambinder & Nina D. Wagner-Johnston. 2008. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
1061
1071
.
Richard F. LittleKaren AlemanPallavi KumarKathleen M. WyvillJames M. PludaElizabeth Read-ConnoleVictoria WangStefania Pittaluga, Andrew T. CatanzaroSeth M. Steinberg & Robert Yarchoan. (2007) Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcoma. Blood 110:13, pages 4165-4171.
Crossref
Crossref
Timothy Cooley, David Henry, Margaret Tonda, Steven Sun, Martin O'Connell & Wayne Rackoff. (2007) A Randomized, Double-Blind Study of Pegylated Liposomal Doxorubicin for the Treatment of AIDS-Related Kaposi's Sarcoma. The Oncologist 12:1, pages 114-123.
Crossref
Crossref
R. Di Trolio, G. Di Lorenzo, M. Delfino & S. De Placido. (2016) Role of Pegylated Lyposomal Doxorubicin (PLD) in Systemic Kaposi's Sarcoma: A Systematic Review. International Journal of Immunopathology and Pharmacology 19:2, pages 253-263.
Crossref
Crossref
Karl Wilkins, Ryan Turner, Jacqueline C. Dolev, Philip E. LeBoit, Timothy G. Berger & Toby A. Maurer. (2006) Cutaneous malignancy and human immunodeficiency virus disease. Journal of the American Academy of Dermatology 54:2, pages 189-206.
Crossref
Crossref
Tony Antoniou & Alice L Tseng. (2005) Interactions Between Antiretrovirals and Antineoplastic Drug Therapy. Clinical Pharmacokinetics 44:2, pages 111-145.
Crossref
Crossref
Karl Wilkins, Jacqueline C. Dolev, Ryan Turner, Philip E. LeBoit, Timothy G. Berger & Toby A. Maurer. (2005) Approach to the treatment of cutaneous malignancy in HIV-infected patients. Dermatologic Therapy 18:1, pages 77-86.
Crossref
Crossref
F.J. Andreu Martínez & J.M. Martínez Mateu. (2005) Radioterapia en el tratamiento del sarcoma de Kaposi epidémico bucofaríngeo. Acta Otorrinolaringológica Española 56:8, pages 368-372.
Crossref
Crossref
Susan E. Krown, Donald W. Northfelt, David Osoba & J. Simon Stewart. (2004) Use of liposomal anthracyclines in Kaposi’s sarcoma. Seminars in Oncology 31, pages 36-52.
Crossref
Crossref
Giorgio Minotti, Pierantonio Menna, Emanuela Salvatorelli, Gaetano Cairo & Luca Gianni. (2004) Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity. Pharmacological Reviews 56:2, pages 185-229.
Crossref
Crossref
Manisha H. Shah, Pierluigi Porcu, Susan R. Mallery & Michael A. Caligiuri. 2003.
717
746
.
Luca Gianni, Giacomo Grasselli, Sara Cresta, Alberta Locatelli, Lucia Viganò & Giorgio Minotti. 2003.
29
40
.